Integra Lifesciences Holdings (IART) Capital Expenditures (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Capital Expenditures of $12.3 million for Q2 2026, down 17.11% sequentially from $14.8 million in Q1 2026, and down 38.91% YoY from $20.1 million in Q2 2025.
Integra Lifesciences Holdings (IART) Capital Expenditures (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Capital Expenditures for 18 years, with the latest figure at $12.3 million in Q2 2026.
- Quarterly Capital Expenditures fell 38.91% year-over-year to $12.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $59.5 million (down 45.04% YoY) and the FY2025 annual result came in at $81.4 million, down 22.01% from the prior year.
- Capital Expenditures eased to $12.3 million in Q2 2026 per IART's latest filing, from $14.8 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $29.7 million in Q2 2024 and troughed at $9.2 million in Q3 2022.
- A 5-year average of $17.9 million and a median of $15.3 million in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures surged 126.69% in 2024, then tumbled 48.88% in 2025.
- Over 5 years, Capital Expenditures stood at $14.5 million in 2022, then surged by 69.72% to $24.5 million in 2023, then advanced by 20.64% to $29.6 million in 2024, then sank by 41.84% to $17.2 million in 2025, then retreated by 28.51% to $12.3 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $12.3 million, $14.8 million, and $17.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | 12.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.31 Mn |
| Jun 30, 2026 | 12.31 Mn |
| Mar 31, 2026 | 14.85 Mn |
| Mar 31, 2026 | 14.85 Mn |
| Dec 31, 2025 | 17.21 Mn |
| Dec 31, 2025 | 17.21 Mn |
| Sep 30, 2025 | 15.16 Mn |
| Sep 30, 2025 | 15.16 Mn |
| Jun 30, 2025 | 20.15 Mn |
| Jun 30, 2025 | 20.15 Mn |
| Mar 31, 2025 | 28.92 Mn |
| Mar 31, 2025 | 28.92 Mn |
| Dec 31, 2024 | 29.60 Mn |
| Dec 31, 2024 | 29.60 Mn |
| Sep 30, 2024 | 29.65 Mn |
| Sep 30, 2024 | 29.65 Mn |
| Jun 30, 2024 | 29.71 Mn |
| Jun 30, 2024 | 29.71 Mn |
| Mar 31, 2024 | 15.47 Mn |
| Mar 31, 2024 | 15.47 Mn |